413 related articles for article (PubMed ID: 28898730)
1. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
[TBL] [Abstract][Full Text] [Related]
2. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
[TBL] [Abstract][Full Text] [Related]
3. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
5. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
7. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
8. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.
Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP
PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846
[TBL] [Abstract][Full Text] [Related]
11. An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs.
Schnee M; Vogel AB; Voss D; Petsch B; Baumhof P; Kramps T; Stitz L
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004746. PubMed ID: 27336830
[TBL] [Abstract][Full Text] [Related]
12. [Immune efficacy of rabies virus glycoprotein expressed by baculovirus vector].
Chen Q; Zhang SF; Liu Y; Fu YH; Sun CL; Yang Y; Gong T; Song FF; Hu RL
Bing Du Xue Bao; 2012 Sep; 28(5):501-5. PubMed ID: 23233923
[TBL] [Abstract][Full Text] [Related]
13. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R
Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
Park JE; Shin HJ
Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
16. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a recombinant parapoxvirus expressing the spike protein of Porcine epidemic diarrhea virus.
Hain KS; Joshi LR; Okda F; Nelson J; Singrey A; Lawson S; Martins M; Pillatzki A; Kutish GF; Nelson EA; Flores EF; Diel DG
J Gen Virol; 2016 Oct; 97(10):2719-2731. PubMed ID: 27558814
[TBL] [Abstract][Full Text] [Related]
18. A thermostable messenger RNA based vaccine against rabies.
Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
[TBL] [Abstract][Full Text] [Related]
19. Codon optimization of G protein enhances rabies virus-induced humoral immunity.
Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L
J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681
[TBL] [Abstract][Full Text] [Related]
20. A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice.
Li Z; Wang J; Yuan D; Wang S; Sun J; Yi B; Hou Q; Mao Y; Liu W
Virus Genes; 2015 Jun; 50(3):434-41. PubMed ID: 25764477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
